首页> 外国专利> PHARMACEUTICAL FORMULATION OF INDEPENDENT SUSTAINED LIBERATION OF THE IONIC FORCE.

PHARMACEUTICAL FORMULATION OF INDEPENDENT SUSTAINED LIBERATION OF THE IONIC FORCE.

机译:独立维持离子力的药物配方。

摘要

1. A pharmaceutical formulation of a hydrophilic gel forming matrix comprising one or more active substances and having a prolonged release of said one or more active substances after exposure to gastrointestinal fluids, characterized in that said pharmaceutical formulation comprises hydroxypropyl methylcellulose (HPMC ) of high or medium viscosity and a hydroxyethylcellulose (HEC) of high or medium viscosity, in a ratio HPMC / HEC = 1/0, 85 ¿1/1, 2 and optionally a HPMC of low viscosity in a ratio HPMC of high viscosity or medium / low viscosity HPMC = 1/0, 01 ¿1/0, 2.
机译:1.一种亲水性凝胶形成基质的药物制剂,其包含一种或多种活性物质并且在暴露于胃肠液后具有所述一种或多种活性物质的延长释放,其特征在于所述药物制剂包含高或高浓度的羟丙基甲基纤维素(HPMC)。中等粘度和高或中等粘度的羟乙基纤维素(HEC),比例为HPMC / HEC = 1/0,85¿1/1,2,可选的是低粘度的HPMC,比例为高粘度或中等/低比例的HPMC粘度HPMC = 1/0,01¿1/0,2。

著录项

  • 公开/公告号ES2284709T3

    专利类型

  • 公开/公告日2007-11-16

    原文格式PDF

  • 申请/专利权人 SOLVAY PHARMACEUTICALS B.V.;

    申请/专利号ES20010985673T

  • 申请日2001-09-28

  • 分类号A61K9/22;A61K9;A61K9/20;A61K9/28;A61K31/15;A61K31/167;A61K31/439;A61K31/496;A61K31/565;A61K31/57;A61K47/38;A61P1/08;A61P1/12;A61P1/14;A61P3/04;A61P3/06;A61P5/30;A61P7/02;A61P9;A61P9/02;A61P9/04;A61P9/06;A61P9/08;A61P9/10;A61P9/12;A61P13/08;A61P13/12;A61P19/10;A61P25;A61P25/04;A61P25/06;A61P25/08;A61P25/14;A61P25/16;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P29;A61P31/04;A61P31/10;A61P31/12;A61P31/18;A61P33;A61P35;A61P35/04;A61P37;A61P39/02;

  • 国家 ES

  • 入库时间 2022-08-21 20:04:28

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号